| Product Code: ETC7646624 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Israel`s import of blood plasma derivatives in 2024 primarily sourced from Switzerland, Netherlands, Belgium, Germany, and Metropolitan France, showcasing a diverse supplier base. The market concentration, as measured by the HHI, remained at a moderate level, indicating a healthy level of competition among exporters. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a robust 5.89%, with a notable growth rate of 5.98% from 2023 to 2024, highlighting a positive trend in the market`s expansion. This data suggests a promising outlook for the blood plasma derivative import market in Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Blood Plasma Derivative Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Blood Plasma Derivative Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Blood Plasma Derivative Market - Industry Life Cycle |
3.4 Israel Blood Plasma Derivative Market - Porter's Five Forces |
3.5 Israel Blood Plasma Derivative Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Israel Blood Plasma Derivative Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Israel Blood Plasma Derivative Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Israel Blood Plasma Derivative Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring blood plasma derivatives |
4.2.2 Technological advancements in the production and purification of blood plasma derivatives |
4.2.3 Growing demand for immunoglobulins and other plasma-derived products for therapeutic purposes |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the production and distribution of blood plasma derivatives |
4.3.2 High cost associated with the production and storage of blood plasma derivatives |
4.3.3 Limited availability of plasma donors and challenges in ensuring a stable and safe supply chain for plasma collection |
5 Israel Blood Plasma Derivative Market Trends |
6 Israel Blood Plasma Derivative Market, By Types |
6.1 Israel Blood Plasma Derivative Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Blood Plasma Derivative Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Israel Blood Plasma Derivative Market Revenues & Volume, By Albumin, 2022 - 2032F |
6.1.4 Israel Blood Plasma Derivative Market Revenues & Volume, By Factor VII, 2022 - 2032F |
6.1.5 Israel Blood Plasma Derivative Market Revenues & Volume, By Factor IX concentrate, 2022 - 2032F |
6.1.6 Israel Blood Plasma Derivative Market Revenues & Volume, By Anti-coagulation factor, 2022 - 2032F |
6.1.7 Israel Blood Plasma Derivative Market Revenues & Volume, By Rh immunoglobulin, 2022 - 2032F |
6.1.8 Israel Blood Plasma Derivative Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 Israel Blood Plasma Derivative Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Blood Plasma Derivative Market Revenues & Volume, By Immunodeficiency Diseases, 2022 - 2032F |
6.2.3 Israel Blood Plasma Derivative Market Revenues & Volume, By Bleeding Disorders, 2022 - 2032F |
6.2.4 Israel Blood Plasma Derivative Market Revenues & Volume, By Liver Conditions, 2022 - 2032F |
6.2.5 Israel Blood Plasma Derivative Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 Israel Blood Plasma Derivative Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Blood Plasma Derivative Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.3.3 Israel Blood Plasma Derivative Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.3.4 Israel Blood Plasma Derivative Market Revenues & Volume, By Transfusion Centers, 2022 - 2032F |
7 Israel Blood Plasma Derivative Market Import-Export Trade Statistics |
7.1 Israel Blood Plasma Derivative Market Export to Major Countries |
7.2 Israel Blood Plasma Derivative Market Imports from Major Countries |
8 Israel Blood Plasma Derivative Market Key Performance Indicators |
8.1 Average selling price of blood plasma derivatives |
8.2 Number of approved indications for blood plasma derivative products |
8.3 Research and development investments in improving the efficiency of plasma fractionation processes |
9 Israel Blood Plasma Derivative Market - Opportunity Assessment |
9.1 Israel Blood Plasma Derivative Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Israel Blood Plasma Derivative Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Israel Blood Plasma Derivative Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Israel Blood Plasma Derivative Market - Competitive Landscape |
10.1 Israel Blood Plasma Derivative Market Revenue Share, By Companies, 2025 |
10.2 Israel Blood Plasma Derivative Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here